Reduced Expression of GPX3 in Breast Cancer Patients in Correlation with Clinical Significance

Abstract

MGlutathione peroxidase 3 (GPX3) is the main antioxidant enzyme in plasma. Its biological roles are to protect cells from oxidative stress-induced damage. Several studies have been reported the association between GPX3 expression and its correlation with cancer carcinogenesis including breast cancer. The aim of this research was to investigate the GPX3 messenger ribonucleic acid (mRNA) expression in 82 breast tumors and paired normal breast tissues by SYBR green quantitative real-time reverse transcription-polymerase chain reaction and the association with clinicopathological data. Our results show that GPX3 reduced expression was found significantly associated with number of metastatic lymph nodes (odds ratio [OR] = 3.41, 95% confidence interval [CI] = 1.35-8.64, p = 0.01), no distant metastasis (OR = 5.52, 95% CI = 3.74-11.89, p = 0.04), and nonhormone usage breast cancer patients (OR = 0.19, 95% CI = 0.04-0.93, p = 0.04). This finding suggested that GPX3 plays a role in breast carcinogenesis, and might serve as a prognostic biomarker in breast cancer patients.

Keywords

breast cancer / GPX3 / antioxidant enzyme / gene expression / real-time reverse transcription-PCR

References

[1] Baez-Duarte BG, Mendoza-Carrera F, García-Zapién A, et al; Multidisciplinary Research Group on Diabetes of the Instituto Mexicano del Seguro Social. Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome. Arch Med Res 2014; 45(05): 375-382

[2] Liu K, Jin M, Xiao L, Liu H, Wei S. Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer. Cancer Manag Res 2018; 10(10): 2997-3005

[3] Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer. Anticancer Res 2012; 32(08): 3169-3175

[4] Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2000; 2(04): 903-917

[5] Cebrian A, Pharoah PD, Ahmed S, et al. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 2006; 66(02): 1225-1233

[6] Peng DF, Hu TL, Schneider BG, Chen Z, Xu ZK, El-Rifai W. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS One 2012; 7(10): e46214

[7] Zhang X, Zheng Z, Yingji S, et al. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Oncol Rep 2014; 31(06): 2587-2592

[8] Zhao H, Li J, Li X, et al. Silencing GPX3 expression promotes tumor metastasis in human thyroid cancer. Curr Protein Pept Sci 2015; 16(04): 316-321

[9] Yu YP, Yu G, Tseng G, et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67(17): 8043-8050

[10] Qi X, Ng KT, Lian QZ, et al. Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma. Oncotarget 2014; 5(22): 11103-11120

[11] Mohamed MM, Sabet S, Peng DF, Nouh MA, El-Shinawi M, El-Rifai W. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Oxid Med Cell Longev 2014; 2014: 787195

[12] Lou W, Ding B, Wang S, Fu P. Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro. Cancer Cell Int 2020; 20: 378

[13] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25(04): 402-408

[14] Jiao Y, Wang Y, Guo S, et al. Glutathione peroxidases as oncotargets. Oncotarget 2017; 8(45): 80093-80102

[15] Chen H, Zheng Z, Kim KY, Jin X, Roh MR, Jin Z. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. Oncol Rep 2016; 36(05): 2737-2744

[16] Yang ZL, Yang L, Zou Q, et al. Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer. Dis Markers 2013; 35(03): 163-172

RIGHTS & PERMISSIONS

2020 Global Medical Genetics